Anemocyte is pleased to announce its participation in CPHI Europe 2025, taking place in Frankfurt, Germany, from October 28 to 30, 2025, at Messe Frankfurt.
The company will showcase its capabilities at booth 4.1M42 Hall 04.1, located in the BioProduction Zone, one of the core areas dedicated to biotechnological innovation.
Why CPHI Europe matters
CPHI Europe is one of the world’s leading events for the pharmaceutical industry, bringing together tens of thousands of attendees, hundreds of exhibitors, and a comprehensive conference program covering every stage of the pharma value chain.
The 2025 edition will host more than 62,000 visitors and 2,400 exhibitors, featuring dedicated content tracks such as Next-Gen Bio, Manufacturing 5.0, Sustainability, Future of Pharma, Clinical Innovation, and Packaging & Device Innovation.
New thematic areas will also be introduced – including AI & Tech, Cleanroom, Cold Chain & Logistics, and Sustainability Supplier – reflecting the industry’s evolving priorities.
The event will also feature the CPHI Celebration, a networking and award night gathering key players from across the global pharma landscape.
What Anemocyte will bring to Frankfurt
With over 25 years of experience in biotechnology, Anemocyte stands as a Biotech Manufacturing Organization (BMO) offering fully integrated GMP capabilities for pDNA and mRNA manufacturing, supporting gene and cell therapies, vaccines, and advanced therapeutic platforms.
At booth 4.1M42, our team will be available to present Anemocyte’s end-to-end solutions, discuss new partnerships, and share insights on the evolving challenges of bioproduction – from innovation and quality to scalability and sustainability.
Goals and opportunities
- Global visibility: positioning Anemocyte among leading biotech innovators at one of the most influential international stages.
- Qualified networking: connecting directly with decision-makers, researchers, and key industry stakeholders.
- Knowledge sharing: attending sessions and workshops to stay aligned with the latest scientific and regulatory developments.
- New collaborations: exploring strategic partnerships in mRNA, plasmid DNA, gene therapy, and non-viral production solutions.
We invite you to mark your calendars and visit us at booth 4.1M42, BioProduction Zone – a great opportunity to meet our team and shape together the future of biomanufacturing.
